NCT02501174 2026-03-18
CONSOG
Centre Oscar Lambret
Completed
Clinical Trials
65 trialsNCT06298357 2026-03-18
Virtual Reality Gaming for Exercise and Mindfulness Among Pediatric Cancer Rehabilitation
University of Alabama at Birmingham
Phase 1 Completed
NCT00420563 2026-03-16
PAL-ANGI
Centre Oscar Lambret
Phase 2 Completed
NCT01415258 2026-03-16
VULNERABILITE
Centre Oscar Lambret
Completed
NCT06072833 2026-03-16
Characterizing and Addressing Financial Toxicity in AYAs With Cancer
Columbia University
Phase NA Completed
NCT00580515 2026-03-13
Trial of Family Focused Grief Therapy in Palliative Care and Bereavement
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT04442425 2026-03-12
Machine Learning to Analyze Facial Imaging, Voice and Spoken Language for the Capture and Classification of Cancer/Tumor Pain
National Institutes of Health Clinical Center (CC)
Completed
NCT04308356 2026-03-11
ESOP
Assistance Publique - Hôpitaux de Paris
Completed
NCT03833167 2026-03-10
KEYNOTE-630
Merck Sharp & Dohme LLC
Phase 3 Completed
NCT02423057 2026-03-06
Phase I Trial of 4'-Thio-2'-Deoxycytidine (TdCyd) in Patients With Advanced Solid Tumors
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT02840058 2026-03-06
ITHER
Centre Hospitalier Universitaire de Besancon
Phase NA Completed
NCT06048822 2026-03-06
Enhancing Cancer Survivorship With Pickleball
H. Lee Moffitt Cancer Center and Research Institute
Phase NA Completed
NCT06248450 2026-03-06
YouCanPrefer
Linkoeping University
Phase NA Completed
NCT06340815 2026-03-06
Varian ProBeam Proton Therapy System Clinical Trial (Shandong)
Varian, a Siemens Healthineers Company
Phase NA Completed
NCT04142567 2026-03-05
CHOPIN
Assistance Publique - Hôpitaux de Paris
Completed
NCT02394223 2026-03-04
BIOMAGIC01
Assistance Publique - Hôpitaux de Paris
Completed
NCT05148078 2026-03-02
Pediatric Radiation Oncology With Movie Induced Sedation Effect (PROMISE)
University of Texas Southwestern Medical Center
Phase 2 Completed
NCT01602380 2026-02-27
FALCON
AstraZeneca
Phase 3 Completed
NCT05377554 2026-02-27
Bevonescein for Intra-Operative Nerve Visualization in Head and Neck Surgery
Alume Biosciences, Inc.
Phase 3 Completed
NCT05564468 2026-02-27
Design and Testing of a Web-Based Tool for the Improvement of End-of-Life Planning in Patients With Advanced Cancer
Fred Hutchinson Cancer Center
Phase NA Completed
NCT06056791 2026-02-27
CaRe
Inmune Bio, Inc.
Phase 1/2 Completed
NCT03976362 2026-02-25
KEYLYNK-008
Merck Sharp & Dohme LLC
Phase 3 Completed
NCT05024968 2026-02-25
Sintilimab in Cancer of Unknown Primary
M.D. Anderson Cancer Center
Phase 2 Completed
NCT03466957 2026-02-20
Individual Approach in Gynecological Cancer Brachytherapy
Institute of Oncology Ljubljana
Phase NA Completed
NCT06837090 2026-02-20
SPAINTRK
Grupo Espanol de Tumores Neuroendocrinos
Completed
NCT03964233 2026-02-18
A Study in Patients With Different Types of Advanced Cancer (Solid Tumors) to Test Different Doses of BI 907828 (Brigimadlin) in Combination With BI 754091 (Ezabenlimab) and BI 754111 or BI 907828 (Brigimadlin) in Combination With BI 754091 (Ezabenlimab)
Boehringer Ingelheim
Phase 1 Completed
NCT06676436 2026-02-18
REALNESS
AstraZeneca
Completed
NCT04393974 2026-02-17
OnCovid
Imperial College London
Completed
NCT06758011 2026-02-17
ivWatch in Prevention of Extravasation of Vesicants in an Oncology Setting
Roswell Park Cancer Institute
Phase NA Completed
NCT01915797 2026-02-13
TED
Assistance Publique - Hôpitaux de Paris
Completed
NCT03388190 2026-02-13
METIMMOX
University Hospital, Akershus
Phase 2 Completed
NCT05490641 2026-02-13
Project KNOWN
The University of Texas at Arlington
Phase NA Completed
NCT07408661 2026-02-13
Application of Artificial Intelligence and Iron Metabolism Markers in Predicting ICU Outcomes for Critically Ill Cancer Patients
Tongji University
Completed
NCT02212860 2026-02-11
SIGNAL 2
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase NA Completed
NCT01534598 2026-02-10
FdCyd and THU for Advanced Solid Tumors
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT04455698 2026-02-10
ENGAGE
University of Chicago
Phase NA Completed
NCT04966520 2026-02-10
Accelerated Neuromodulation to Alleviate Cognitive Deficits Due to Cancer Therapy
University of Iowa
Phase NA Completed
NCT06170385 2026-02-06
PEACE
University of Alberta
Phase NA Completed
NCT03229837 2026-02-05
Validation Study of Pediatric Patient-Reported Outcomes
St. Jude Children's Research Hospital
Completed
NCT05360498 2026-02-03
Symptom Management for Rural-Urban Cancer Survivors and Caregivers
University of Arizona
Phase NA Completed
NCT06326554 2026-01-30
STEP2
University Health Network, Toronto
Phase NA Completed
NCT04260529 2026-01-29
CICILIA
Cytovation AS
Phase 1/2 Completed
NCT03872778 2026-01-28
NeoRay
Advanced Accelerator Applications
Phase 1/2 Completed
NCT02952248 2026-01-27
A Trial to Find and Investigate a Safe Dose of a New Substance (BI 754091) for Patients With Solid Tumours
Boehringer Ingelheim
Phase 1 Completed
NCT03697304 2026-01-27
Platform Trial Evaluating Safety and Efficacy of Ezabenlimab Anti- PD-1 Based Combination Therapies in PD-(L)1 naïve and PD- (L)1 Pretreated Patient Populations With Advanced/Metastatic Solid Tumours
Boehringer Ingelheim
Phase 2 Completed
NCT07361458 2026-01-23
Modex, a Cloud-based, Centralized Health Economic Model Marketplace to Reduce Costs and Enhance Equity in Cancer
Arnold Consultancy & Technology, LLC
Phase NA Completed
NCT03752333 2026-01-22
CUPem
Imperial College London
Phase 2 Completed
NCT02807129 2026-01-21
AgElOn
CHU de Reims
Phase NA Completed
NCT04429490 2026-01-21
PESTIPAC
CHU de Reims
Phase NA Completed
NCT05594693 2026-01-16
Integrative Health Interventions in Symptom Management of Pediatric Patients
University of Colorado, Denver
Completed